Kwon, H., Shin, J. E., Khan, A., Park, S. Y., Kim, J., Lee, J., . . . Kim, D. KF1601, a dual inhibitor of BCR: :ABL1 and FLT3, overcomes drug resistance in FLT3+ blast phase chronic myeloid leukemia. BMC.
Chicago Style (17th ed.) CitationKwon, Hyun-Jin, et al. KF1601, a Dual Inhibitor of BCR: :ABL1 and FLT3, Overcomes Drug Resistance in FLT3+ Blast Phase Chronic Myeloid Leukemia. BMC.
MLA (9th ed.) CitationKwon, Hyun-Jin, et al. KF1601, a Dual Inhibitor of BCR: :ABL1 and FLT3, Overcomes Drug Resistance in FLT3+ Blast Phase Chronic Myeloid Leukemia. BMC.
Warning: These citations may not always be 100% accurate.